Mitotane
Spezifikationen
53-19-0CAS-Nummer
200-166-6EG-Nummer
1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzeneIUPAC-Name
C14H10Cl4Chemische Formel
320 g/molMolekulargewicht
mitotane; 53-19-0; Mitotan; Lysodren; Chlodithane; Chloditan; o,p'-DDD; 2,4'-Ddd; Mitotano; Opeprim; o,p'-TDE; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene; o,p-Tde; 1-Chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)benzene; Mitotanum; NCI-C04933; 2,4'-Dichlorodiphenyldichloroethane; o,p'-Dichlorodiphenyldichloroethane; CB 313; CB-313; NSC-38721; DTXSID9020372; NSC 38721; O,p'-ddd,o p'-tde; 1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; (o,p)-DDD; 2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane; 1,1-Dichloro-2,2-bis(2,4'-dichlorophenyl)ethane; NSC38721; 2,2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane; 78E4J5IB5J; Ethane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; Ethane, 2-(o-chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloro-; DTXCID30372; 1-chloro-4-[2,2-dichloro-1-(2-chlorophenyl)ethyl]benzene; Khloditan; Mytotan; ortho,para-DDD; ortho,para DDD; 1-chloro-4-(2,2-dichloro-1-(2-chlorophenyl)ethyl)benzene; Lisodren; Opddd; RefChem:56621; L01XX23; 2, 4'-Dichlorodiphenyldichloroethane; WR-13045; 1, 1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 2, 2-Bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane; 200-166-6; Khlodithan; Chlodithan; 1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane; Benzene, 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-; 2,4'-Dichlorophenyldichlorethane; MFCD00000850; 2-(o-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane; Mitotane (Lysodren); 1,1-Dichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane; Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-; 2,4-Ddd; Mitotane (Lsodren); Mitotanum [INN-Latin]; NCGC00015226-07; Mitotano [INN-Spanish]; N-[(7S)-6,7-Dihydro-5-[(4-methoxyphenyl)methyl]-6-oxo-5H-dibenz[b,d]azepin-7-yl]-carbamic Acid (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl Ester; 2,4'-DDD;o,p'-DDD; CB313; DDD, o,p'-; CAS-53-19-0; Lysodren (TN); SMR000326696; CCRIS 4397; HSDB 3240; SR-01000075751; EINECS 200-166-6; (2,4'-Dichlorodiphenyl)dichloroethane; Mitotane (JAN/USP/INN); BRN 2056007; UNII-78E4J5IB5J; AI3-07575; Prestwick_75; Ethane,1-dichloro-; Mitotane (Standard); Mitotane [USAN:USP:INN:BAN:JAN]; Spectrum_001959; MITOTANE [HSDB]; MITOTANE [USAN]; DDD-o,p'; MITOTANE [INN]; MITOTANE [JAN]; MITOTANE [MI]; MITOTANE [VANDF]; (+-)-1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; Spectrum2_000916; Spectrum3_000869; Spectrum4_000709; Spectrum5_002060; MITOTANE [MART.]; MITOTANE [USP-RS]; MITOTANE [WHO-DD]; C 3010; (o,p')-DDD; SCHEMBL4040; CHEMBL1670; MITOTANE [EMA EPAR]; Lopac0_000251; WLN: GYGYR BG&R DG; BSPBio_002517; KBioGR_001237; KBioSS_002513; SPECTRUM330082; Mitotane - Bio-X trade mark; MLS001335899; MLS001335900; MLS002152914; MLS002153233; 2,4-DDD;o,p'-DDD; DivK1c_000703; SPBio_000792; MITOTANE [ORANGE BOOK]; CHEBI:6954; GTPL6957; orb1224775; orb1309439; orb3025313; MITOTANE [USP IMPURITY]; Mitotane, >=98% (HPLC); MITOTANE [USP MONOGRAPH]; SCHEMBL29360948; HMS502D05; KBio1_000703; KBio2_002505; KBio2_005073; KBio2_007641; KBio3_002017; NINDS_000703; HMS1923K19; HMS2091E07; HMS2232C16; HMS3260D04; HMS3369H10; HMS3655G06; HMS3715H07; HMS3869F13; HMS5079P18; Pharmakon1600-00330082; LAC39621; MSK20508; Tox21_110103; Tox21_302804; Tox21_500251; CCG-40014; EBC-03725; HY-13690R; NSC755849; s1732; 1,2-bis(2,4'-dichlorophenyl)ethane; AKOS006028802; Benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-, (+-)-; Tox21_110103_1; CS-1500; DB00648; FM02907; LP00251; NSC-755849; SDCCGSBI-0050239.P006; IDI1_000703; 2,4'-DDD 10 |Ig/mL in Cyclohexane; NCGC00015226-02; NCGC00015226-03; NCGC00015226-04; NCGC00015226-05; NCGC00015226-06; NCGC00015226-08; NCGC00015226-09; NCGC00015226-10; NCGC00015226-11; NCGC00015226-12; NCGC00015226-22; NCGC00091374-01; NCGC00091374-02; NCGC00091374-03; NCGC00091374-04; NCGC00091374-05; NCGC00091374-06; NCGC00256452-01; NCGC00260936-01; 2,4'-DDD 10 microg/mL in Cyclohexane; 2,4'-DDD 100 |Ig/mL in Cyclohexane; AS-11690; BM300096; HY-13690; NCI60_003688; 2,4'-DDD 100 microg/mL in Cyclohexane; SBI-0050239.P004; EU-0100251; M3304; M3576; NS00009562; ST51016017; SW199619-3; EN300-37268; 2,4 inverted exclamation marka-DDD;o,p'-DDD; 2,4'-DDD, PESTANAL(R), analytical standard; C75491; D00420; AB00052337-09; AB00052337_10; F825704; Q417465; SR-01000075751-1; SR-01000075751-3; SR-01000075751-6; BRD-A31204924-001-13-4; BRD-A31204924-001-14-2; BRD-A31204924-001-16-7; BRD-A31204924-001-17-5; 2,4'-(2,2-dichloroethane-1,1-diyl)bis(chlorobenzene); Z381079728; 1-(o-Chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane; 1-[2,2-dichloro-1-(4-chlorophenyl)ethyl]-2-chlorobenzene; Ethane,1-dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)-; 1-Chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene #; Mitotane, United States Pharmacopeia (USP) Reference Standard; (+/-)-1,1-DICHLORO-2-(O-CHLOROPHENYL)-2-(P-CHLOROPHENYL)ETHANE; BENZENE, 1-CHLORO-2-(2,2-DICHLORO-1-(4-CHLOROPHENYL)ETHYL)-, (+/-)-Synonyme
